Homepage, Hege G. Russnes group:
Genomic alterations in breast cancer with impact on prognosis, therapy prediction and clinical follow-up
The focus of the group is translational research on breast cancer with a special focus on molecular diagnostics. Hege G. Russnes is a specialist in patology and also holds a 50% position as senior consultant in the Department of Pathology, OUS (molecular pathology and breast pathology). She is a member of the steering committee of OSBREAC (Oslo Breast Cancer Research Consortium) and in the K. G. Jebsen Center for Breast Cancer Research.
The group has the following main areas of interest:
- Intra tumor heterogeneity of breast cancer.
- Molecular classification of breast cancer.
- Circulating biomarkers for breast cancer.
- Tumor evolution.
Hege G. Russnes, Dept. of Genetics, Institute for Cancer Research, Oslo University Hospital, PB. 0424 Oslo, Norway. Email: firstname.lastname@example.org
Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology
Mar 15, 2017
Prestigious research prize from the Norwegian Cancer Society to pioneer in autophagy research
Mar 7, 2017
Mar 6, 2017
Mar 2, 2017
Hege G. Russnes
Glycan-related gene expression signatures in breast cancer subtypes; relation to survival
Mol Oncol, 9 (4), 861-76
Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors
Genes Chromosomes Cancer, 54 (4), 235-48
eEF2K--a new target in breast cancers with combined inactivation of p53 and PTEN
EMBO Mol Med, 6 (12), 1512-4